PRTN3 and rheumatoid arthritis: In particular in RA, several types of autoantibodies have been identified that target a range of subtle chemical modifications of autologous proteins, including anti-citrullinated protein antibodies (ACPA) and anti-carbamylated protein antibodies—which may be referred to collectively as anti-modified protein response (31).